Biktarvy Tab

DRUG2 trials

Sponsors

Southampton Healthcare, Inc., Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba

Conditions

HIV-1-infectionHIV-infected Patient Kidney Transplant Recipient

Phase 4

Testing the Safety and Efficacy of Commercial Drug Biktarvy in Subjects Known to Have the 184 Resistance Mutation to a Component in Biktarvy

TerminatedNCT04040075

Southampton Healthcare, Inc.HIV-1-infection

Start: 2019-07-01End: 2022-07-08Updated: 2023-01-05

Pharmacokinetics of Calcineurin & mTOR Inhibitors in HIV-1 Infected Kidney Transplant Recipients After Switch to BIC/FTC/TAF

Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'BaHIV-infected Patient Kidney Transplant Recipient

Start: 2022-09-29End: 2024-07-01Updated: 2023-05-25